BMC Cancer 2004, 4:78 http://www.biomedcentral.com/1471-2407/4/78 the class of cancer/testis antigens. Proc Natl Acad Sci USA 1998, 95(9):5211-5216. 11. Jager D, Unkelbach M, Frei C, Bert F, Scanlan MJ, Jager E, Old LJ, Chen Y-T, Knuth A: Identification of tumor-restricted antigens NY- BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer. Cancer Immunity 2002, 2:5. 12. Sternberg N, Hoess RH: Display of peptides and proteins on the surface of bacteriophage λ. Proc Natl Acad Sci USA 1995, 92:1609-1613. 13. Sambrook J, Fritsch EF, Maniatis T: Molecular cloning: A labora- tory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor; 1989. 14. Eichmuller S, Usener D, Dummer R, Stein A, Thiel D, Schadendorf D: Serological detection of cutaneous T-cell lymphoma-associ- ated antigens. Proc Natl Acad Sci USA 2001, 98(2):629-634. 15. Scanlan MJ, Gout I, Gordon CM, Williamson B, Stockert E, Gure AO, Jager D, Chen YT, Mackay A, O'Hare MJ, Old LJ: Humoral immu- nity to human breast cancer: antigen definition and quanti- tative analysis of mRNA expression. Cancer Immun 2001, 1:4. 16. Nakatsura T, Senju S, Yamada K, Jotsuka T, Ogawa M, Nishimura Y: Gene cloning of immunogenic antigens overexpressed in pancreatic cancer. Biochem Biophys Res Commun 2001, 281(4):936-944. 17. Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD, Tureci O, Sahin U, Pfreundschuh M, Old LJ: Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 1998, 76(5):652-658. 18. Zhumabayeva B, Diatchenko L, Chenchik A, Siebert PD: Use of SMART-generated cDNA for gene expression studies in multiple human tumors. Biotechnique 2001, 30(1):158-163. 19. Thomas E, Berner G: Prognostic and predictive implications of HER2 status for breast cancer patients. Eur J Oncol Nurs 2000, 4(Sa):10-17. 20. Latta EK, Tjan S, Parkes RK, O'Malley FP: The role of HER2/neu overexpression/ amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast. Mod Pathol 2002, 15(12):1318-1325. 21. Chardin P, Camonis JH, Gale NW, van Aelst L, Schlessinger J, Wigler MH, Bar-Sagi D: Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. Science 1993, 260(5112):1338-1343. 22. Sibilia M, Fleischmann A, Behrens A, Stingl L, Carroll J, Watt FM, Sch- lessinger J, Wagner EF: The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development. Cell 2000, 102(2):211-220. 23. Hart TC, Zhang Y, Gorry MC, Hart PS, Cooper M, Marazita ML, Marks JM, Cortelli JR, Pallos D: A mutation in the SOS1 gene causes hereditary gingival fibromatosis type 1. Am J Hum Genet 2002, 70(4):943-954. 24. Witczak O, Skalhegg BS, Keryer G, Bornens M, Tasken K, Jahnsen T, Orstavik S: Cloning and characterization of a cDNA encoding an A-kinase anchoring protein located in the centrosome, AKAP450. EMBO J 1999, 18(7):1858-1868. 25. Takahashi M, Yamagiwa A, Nishimura T, Mukai H, Ono Y: Centro- somal proteins CG-NAP and kendrin provide microtubule nucleation sites by anchoring gamma-tubulin ring complex. Mol Biol Cell 2002, 13(9):3235-3245. 26. Sillibourne JE, Milne DM, Takahashi M, Ono Y, Meek DW: Centro- somal anchoring of the protein kinase CK1delta mediated by attachment to the large, coiled-coil scaffolding protein CG- NAP/AKAP450. J Mol Biol 2002, 322(4):785-797. 27. Costache M, Cailleau A, Fernandez-Mateos P, Oriol R, Mollicone R: Advances in molecular genetics of alpha-2- and alpha-3/4- fucosyltransferases. Transfus Clin Biol 1997, 4(4):367-382. 28. Paulson JC, Colley KJ: Glycosyltransferases: Structure, localiza- tion, and control of cell type-specific glycosylation. J Biol Chem 1989, 264(30):17615-17618. 29. Smedley D, Hamoudi R, Lu YJ, Cooper C, Shipley J: Cloning and mapping of members of the MYM family. Genomics 1999, 60(2):244-247. 30. Sahin U, Tureci O, Pfreundschuh M: Serological identification of human tumor antigens. Curr Opin Immunol 1997, 9:709-716. 31. Nanbru C, Prats AC, Droogmans L, Defrance P, Huez G, Kruys V: Translation of the human c-myc P0 tricistronic mRNA involves two independent internal ribosome entry sites. Oncogene 2001, 20(31):4270-4280. 32. Gure AO, Altorki NK, Stockert E, Scanlan MJ, Old LJ, Chen YT: Human lung cancer antigens recognized by autologous anti- bodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3. Cancer Res 1998, 58(5):1034-1041. 33. Scanlan MJ, Gordan JD, Williamson B, Stockert E, Bander NH, Jonge- neel V, Gure AO, Jager D, Jager E, Knuth A, Chen YT, Old LJ: Anti- gens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer 1999, 83(4):456-464. 34. Schultz J, Milpetz F, Bork P, Ponting CP: SMART, a simple modu- lar architecture research tool: identification of signaling domains. Proc Natl Acad Sci USA 1998, 95(11):5857-5864. 35. Letunic I, Goodstadt L, Dickens NJ, Doerks T, Schultz J, Mott R, Cic- carelli F, Copley RR, Ponting CP, Bork P: Recent improvements to the SMART domain-based sequence annotation resource. Nucleic Acids Res 2002, 30(1):242-244. 36. Stockert E, Jager E, Chen YT, Scanlan MJ, Gout I, Karbach J, Arand M, Knuth A, Old LJ: A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med 1998, 187(8):1349-1354. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2407/4/78/prepub Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical research in our lifetime." Sir Paul Nurse, Cancer Research UK Your research papers will be: available free of charge to the entire biomedical community peer reviewed and published immediately upon acceptance cited in PubMed and archived on PubMed Central yours — you keep the copyright Submit your manuscript here: http://www.biomedcentral.com/info/publishing_adv.asp BioMedcentral Page 10 of 10 (page number not for citation purposes)